17.16
Edgewise Therapeutics Inc 주식(EWTX)의 최신 뉴스
Edgewise Therapeutics (EWTX): RBC Capital Raises Price Target to - GuruFocus
Does Edgewise Therapeutics Inc. show high probability of reboundWeekly Volume Report & Target Return Focused Picks - newser.com
What valuation multiples suggest for Edgewise Therapeutics Inc. stockBuy Signal & Technical Pattern Based Signals - newser.com
RBC Adjusts Price Target on Edgewise Therapeutics to $50 From $49, Maintains Outperform Rating - MarketScreener
How to track smart money flows in Edgewise Therapeutics Inc.Quarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
Real time breakdown of Edgewise Therapeutics Inc. stock performanceOptions Play & High Accuracy Swing Trade Signals - newser.com
Wedbush Lowers Price Target on Edgewise Therapeutics to $32 From $35, Keeps Outperform Rating - MarketScreener
Edgewise Therapeutics (NASDAQ: EWTX) sets Nov–Dec investor fireside chats; webcasts - Stock Titan
Edgewise Therapeutics Inc. stock prediction for this weekJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - newser.com
Risk vs reward if holding onto Edgewise Therapeutics Inc.July 2025 Pullbacks & Low Drawdown Investment Strategies - newser.com
Edgewise Therapeutics Reports Q3 2025 Financial Results - TipRanks
Decoding Edgewise Therapeutics Inc (EWTX): A Strategic SWOT Insi - GuruFocus
Edgewise Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Edgewise Therapeutics' Q3 Net Loss Widens, Beats Estimate; Shares Rise - MarketScreener
Edgewise Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings Flash (EWTX) Edgewise Therapeutics Posts Q3 Net Loss $0.39 a Share, vs. FactSet Est of $0.42 Loss - MarketScreener
Edgewise Therapeutics Q3 net loss widens as R&D costs rise - MarketScreener
[8-K] Edgewise Therapeutics, Inc. Reports Material Event | EWTX SEC FilingForm 8-K - Stock Titan
[10-Q] Edgewise Therapeutics, Inc. Quarterly Earnings Report | EWTX SEC FilingForm 10-Q - Stock Titan
Edgewise Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire
Chart overlay techniques for tracking Edgewise Therapeutics Inc.2025 Market Trends & Weekly High Return Stock Forecasts - newser.com
Is Edgewise Therapeutics Inc. stock supported by innovation pipelineJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - newser.com
Multi asset correlation models including Edgewise Therapeutics Inc.Volume Spike & Verified Chart Pattern Signals - newser.com
Strategies to average down on Edgewise Therapeutics Inc.2025 Dividend Review & Verified Entry Point Detection - newser.com
Real time alert setup for Edgewise Therapeutics Inc. performancePortfolio Return Report & Smart Money Movement Alerts - newser.com
What hedge fund activity signals for Edgewise Therapeutics Inc. stock2025 Market Sentiment & Growth Focused Investment Plans - newser.com
Is Edgewise Therapeutics Inc. trending in predictive chart modelsPortfolio Return Report & Free Technical Confirmation Trade Alerts - newser.com
Risk adjusted return profile for Edgewise Therapeutics Inc. analyzedJuly 2025 Review & Capital Efficiency Focused Strategies - newser.com
How Edgewise Therapeutics Inc. stock reacts to oil pricesPortfolio Update Report & Long-Term Capital Growth Ideas - fcp.pa.gov.br
Detecting price anomalies in Edgewise Therapeutics Inc. with AIEarnings Overview Report & Growth Focused Entry Point Reports - newser.com
Published on: 2025-11-05 01:23:25 - newser.com
Exit strategy if you’re trapped in Edgewise Therapeutics Inc.Options Play & Daily Growth Stock Tips - newser.com
Published on: 2025-11-04 23:53:31 - newser.com
Analyzing Edgewise Therapeutics Inc. with risk reward ratio charts2025 Momentum Check & Safe Capital Growth Tips - newser.com
How Edgewise Therapeutics Inc. stock performs in stagflationJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - Lelezard
Truist Securities reiterates Buy rating on Edgewise Therapeutics stock By Investing.com - Investing.com Canada
Edgewise Therapeutics prepares for pivotal research in cardiovascular medicine - Traders Union
Can Edgewise Therapeutics Inc. stock beat analyst upgradesJuly 2025 Trade Ideas & Daily Technical Forecast Reports - newser.com
자본화:
|
볼륨(24시간):